Medicare Home Infusion Therapy Benefit
Developed a model to analyze the Medicare spending impact resulting from legislation that would explicitly provide home infusion therapy benefit coverage for certain Part B drugs.
Developed a model to analyze the Medicare spending impact resulting from legislation that would explicitly provide home infusion therapy benefit coverage for certain Part B drugs. Analysis was used to bolster the manufacturer’s congressional lobbying efforts, and was presented as ready-made advocacy materials.
CEO insights
Related articles
Real analysis from people who’ve been there
Evaluation of Biosimilar Utilization by Hospital Types
Worked with a pharmaceutical trade organization to identify biosimilars of interest.
Advocacy Coalition for Uptake of Comprehensive Genomic Profiling
Worked with a diverse group of industry stakeholders including diagnostics manufacturers, laboratories, academic institutions, and disease-specific advocacy groups to redefine comprehensive genomic profiling through the creation of a “new narrative”.
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.